3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 3
1
Phase 2/3
1
Status
Completed
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
1
Conditions
Vomiting
2
Nausea
2
Breast Neoplasms
2
Neoplasms
1
Interventions
Palonosetron
13
Aprepitant
13
Dexamethasone
11
Ondansetron
10
fosaprepitant
4
Olanzapine
4
Granisetron
3
Calcium Dobesilate
3
ramosetron
2
netupitant
2
Tropisetron
2
Radiotherapy
2
Fluorouracil
2
rolapitant
1
netupitant, palosentron drug combination
1
ginger extract
1
dolasetron
1
casopitant
1
Yoga
1
Therapeutics
1
Serotonin 5-HT3 Receptor Antagonists
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiation
1
Pantoprazole
1
Paclitaxel
1
Oxaliplatin
1
Octreotide
1
Megestrol Acetate
1
Megestrol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Vomiting
×
netupitant
×
Clear all
NCT03204279
2024-06-25
CINV
Helsinn Healthcare SA
Phase 2
Completed
67 enrolled
12 charts
NCT03862144
2019-03-05
GIM15-NEPA
Consorzio Oncotech
Phase 2
Completed
150 enrolled